Candesartan Cilexetil Impurity E

Candesartan Cilexetil

Candesartan Cilexetil Impurity E, Candesartan Cilexetil, 914613-35-7, 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester; 1H-N1-Ethyl Candesartan Cilexetil; Candesartan Cilexetil N1-Ethyl Analog; Candesartan cilexetil-9a-N-ethyl; 1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2'-(N-ethyl-tetrazol-5-yl) biphenyl-4-yl]methyl}benzimidazole-7-carboxylate (USP)

Anant Pharmaceuticals Pvt. Ltd. is the renowned and Authentic Manufacturer and Supplier of Candesartan Cilexetil Impurity E in India.

At Anant, we have expertise in synthetic organic chemistry and pharmaceutical analysis and we provide cost effective and accurate custom research services to the industry.

Availability: Please Enquire. For Exact delivery date, please contact sales@anantlabs.com

  • CAT No. : ANT-CDS-08
    CAS No. : 914613-35-7
    Inventory Status : Please Enquire
    Synonym : 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester; 1H-N1-Ethyl Candesartan Cilexetil; Candesartan Cilexetil N1-Ethyl Analog; Candesartan cilexetil-9a-N-ethyl; 1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2'-(N-ethyl-tetrazol-5-yl) biphenyl-4-yl]methyl}benzimidazole-7-carboxylate (USP)
    Mol. formula : C35H38N6O6
    Mol. Weight : 638.71
  • Do you want a quotation or have a question about 'Candesartan Cilexetil Impurity E' ? We normally respond within 2 hours.

Related Candesartan Cilexetil impurities Products

Candesartan Cilexetil - Impurity I

Candesartan Cilexetil
CAT Number: ANT-CDS-10
CAS Number: 139481-69-9

Candesartan Cilexetil Impurity F

Candesartan Cilexetil
CAT Number: ANT-CDS-09
CAS Number: 914613-36-8

Candesartan Cilexetil Impurity D

Candesartan Cilexetil
CAT Number: ANT-CDS-07
CAS Number: 1185256-03-4

Enquire Now!

X

Please fill out the form below and we will get back to you as soon as possible.